We have scheduled some maintenance on Saturday 4th of May 2024 starting from 10AM CEST and could last for 2 hours. During this maintenance we are expecting our website to be unavailable or not fully functional.
US40145Q5009 - Common Stock
Pre-market stock movers are worth checking out as we get into all of the hottest news investors need to know about on Tuesday morning!
Viactiv® Product Line Generated Net Revenues of Approximately $11.9 Million for the Year Ended December 31, 2023, an Increase of Approximately 12% as...
Guardion Health Sciences stock is rising higher on Wednesday as investors in GHSI react to it selling its Viactiv brand and business.
Pre-market stock movers are a hot topic on Wednesday as we check out all of the biggest ones worth keeping an eye on this morning!
HOUSTON, TEXAS, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”) announced today that it has...
Viactiv® Generated Net Revenues of Approximately $3.3 Million for the Three Months Ended September 30, 2023, an increase of 27% over the Three Months Ended...
Viactiv® Product Line Total Revenue Increased Approximately 6% for the Six Months Ended June 30, 2023, as Compared to the Six Months Ended June 30, 2022;...
It's time to start the day off right with a breakdown of the biggest pre-market stock movers traders need to watch on Thursday!
Former President and Chief Executive Officer Bret Scholtes Resigning to Pursue Other Business Opportunities...
Viactiv® Product Line Total Revenue Increased approximately 37% for the Quarter Ended March 31, 2023 as compared to the Quarter Ended March 31, 2022...
Viactiv® Product Line Generated Net Revenues of approximately $10.6 Million or 96% of Net Revenues for the Year Ended December 31, 2022...
HOUSTON, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc (“Guardion” or the “Company”) (NASDAQ: GHSI) announced today that it has...
HOUSTON, Jan. 06, 2023 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (NASDAQ: GHSI) announced today that it will...
This article makes a bullish case for seven penny stocks with buy ratings, and gives you reasons why they may still be risky.
HOUSTON, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), a clinical nutrition company that...
Viactiv® Generated Net Revenues of Approximately $2.6 Million or 96% of Net Revenues for the Quarter Ended September 30, 2022 Company Announces Program to...
We're starting the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday morning!
New Viactiv Omega Boost™ Gel Bites Clinically Proven to Increase Omega-3 Levels by 51% in Just 4 Weeks First-Ever Clinically Proven Gel Bites, with a...
Viactiv® Product Line Contributes to Highest Quarterly Revenue in Company History of Approximately $3.275 Million, Shows Significant Revenue Growth from...
HOUSTON, June 09, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (NASDAQ: GHSI) announced that independent proxy...
These seven undervalued penny stocks each have the potential to pay off for investors down later down the road.
HOUSTON, June 01, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI) announced an agreement with...
Consumers May Now Purchase Viactiv Omega Boost 1,200 mg Omega-3 Gel Bites Directly from Amazon Viactiv Omega Boost Gel Bites Provide 10x More...